Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations (Details)

v3.25.0.1
Discontinued Operations (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
May 17, 2024
Dec. 31, 2023
Dec. 31, 2023
Jun. 30, 2024
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Loss recorded in discontinued operations   $ 3,723,000 $ 4,395,000  
iBio CDMO, LLC | Discontinued Operations        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Loss recorded in discontinued operations   3,723,000 4,395,000  
Fixed asset impairment charge   3,100,000 3,100,000 $ 3,100,000
Interest charges on term note   $ 316,000 674,000  
Loss on sale of fixed assets     $ (50,000) $ 4,800,000
iBio CDMO, LLC | Discontinued Operations | 2024 Purchase and Sale Agreement - The Board of Regents        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Purchase price of facility under ground lease agreement $ 8,500,000